Case report
A 15-year-old female with a complex medical history, including Trisomy 21, spina bifida, atrioventricular septal defect, left ventricular outflow tract obstruction, severe mitral valve regurgitation, and neurogenic bladder managed via vesicostomy drainage, presented to the emergency department with an acute onset of left-sided weakness and aphasia. Clinical examination raised concern for a cerebrovascular accident, and a head CT confirmed a right middle cerebral artery infarct. Given her underlying cardiac anomalies, an embolic aetiology was suspected.
A transesophageal echocardiogram revealed endocarditis involving the anterior leaflet of the mitral valve, with vegetation measuring 0.65–0.75 cm. Blood cultures from an outside facility grew Aerococcus urinae after approximately 48 hours. The patient was started on a combination of ceftriaxone and metronidazole. Due to the elevated risk of haemorrhagic transformation associated with anticoagulation in the context of a recent large stroke, surgical intervention was deferred until the patient’s neurological status stabilised. Despite multiple negative follow-up blood cultures, a repeat transesophageal echocardiogram demonstrated persistent vegetation, left ventricular outflow tract obstruction, and severe mitral valve regurgitation, prompting the decision to proceed with surgery.
Intraoperatively, the substrate causing left ventricular outflow tract obstruction was resected, and the mitral valve vegetation was excised. However, mitral regurgitation and stenosis persisted following the initial repair. Consequently, the mitral valve was replaced with a 19 mm St Jude prosthetic Mitral valve. Postoperative transesophageal echocardiogram confirmed satisfactory function of the prosthetic mitral valve and improved left ventricular outflow tract gradient (Figure 1). Pathological examination of the excised tissue showed no evidence of active infection.
The patient completed a six-week course of gentamicin and penicillin and was subsequently discharged in stable condition on anticoagulation. She continues to do well, with no significant left ventricular outflow tract obstruction and good prosthetic valve function, though she remains at elevated risk for recurrent infective endocarditis due to her underlying cardiac and urinary tract anomalies.
Discussion
A. urinae is an emerging alpha-haemolytic, gram-positive coccus increasingly recognised as a pathogen in invasive infections, including infective endocarditis. Reference Banerjee, Murali, Azhar, Pathmanathan and Chaudhuri1,Reference Ahmed, Bardia, Judge, Ahmad, Malozzi and Calderon2 Its identification is often hindered by phenotypic similarities to Staphylococcus and Enterococcus, leading to underdiagnosis. Reference Ahmed, Bardia, Judge, Ahmad, Malozzi and Calderon2 While 16S rRNA gene sequencing remains the gold standard for species identification, its cost and limited availability restrict routine use. Reference Ahmed, Bardia, Judge, Ahmad, Malozzi and Calderon2,Reference Ludhwani, Li, Huang, Sikora and Thomas4 Matrix-assisted laser desorption ionisation time-of-flight mass spectrometry offers a faster, more accessible alternative by matching bacterial protein mass spectra to reference libraries. Reference Sugaya, Muraoka, Doi and Kawahito3 Additionally, fluorescence in situ hybridisation has shown promise in identifying A. urinae in culture-negative infective endocarditis cases and visualising biofilm activity. Reference Yaban, Kikhney and Musci5
The pathogenesis of A. urinae involves biofilm formation and platelet activation on infected tissues, contributing to immune evasion and embolic complications. Infective endocarditis due to A. urinae carries a high mortality rate, approaching 50%, underscoring the importance of early recognition and targeted therapy. Reference Sugaya, Muraoka, Doi and Kawahito3
Risk factors include advanced age, male gender, structural cardiac anomalies, and urinary tract abnormalities. Although paediatric cases are rare, three have been reported, including our case. All involved congenital heart defects and urinary tract issues. Our patient, a 15-year-old female with atrioventricular septal defect and neurogenic bladder, presented with embolic stroke secondary to mitral valve infective endocarditis.
Our patient received a 4-week course of ceftriaxone and metronidazole, followed by mitral valve replacement and a 6-week postoperative regimen of gentamicin and penicillin. The two previously reported paediatric cases also underwent surgical management and combination antibiotic therapy, resulting in favourable outcomes. Reference Sous, Piwoz, Baer and Bhavsar7,Reference Qureshi and Patel8 These cases highlight the need for heightened clinical suspicion, timely diagnosis, and a multidisciplinary approach to improve prognosis in paediatric A. urinae endocarditis.
A. urinae is an alpha-haemolytic, gram-positive coccus that is an emerging pathogen for invasive infections. Reference Banerjee, Murali, Azhar, Pathmanathan and Chaudhuri1,Reference Ahmed, Bardia, Judge, Ahmad, Malozzi and Calderon2 A. urinae is often misidentified as Staphylococcus as they both display semi-transparent colonies and appear in pairs, tetrads, or clusters on blood agar plates. Reference Ahmed, Bardia, Judge, Ahmad, Malozzi and Calderon2 As a consequence of these diagnostic barriers, the role of A. urinae in the development of invasive infections, such as endocarditis, is underappreciated, and the present body of literature is fairly limited. We present the third reported case of A. urinae infective endocarditis in the paediatric population.
The mortality rate of infective endocarditis caused by A. urinae can reach approximately 50%. Reference Sugaya, Muraoka, Doi and Kawahito3 Prompt diagnosis of A. urinae as the causative pathogen of infective endocarditis and establishing appropriate treatment can crucially improve the mortality outcome. While the gold standard for identification of Aerococcus species is 16S ribosomal RNA gene sequencing, this method is rarely used due to its high cost and limited availability. Reference Ahmed, Bardia, Judge, Ahmad, Malozzi and Calderon2,Reference Ludhwani, Li, Huang, Sikora and Thomas4 Matrix-assisted laser desorption ionisation time-of-flight mass spectrometry is a faster, more accessible method of A. urinae identification, which is divided into two processes: a laser is used to ionise the sample (matrix-assisted laser desorption ionisation), then the ions are detected through time-of-flight mass spectrometry. Bacterial identification is then based on pattern matching between the protein mass spectrum of the tested bacteria and the mass spectrum data of the bacteria in the library. Reference Sugaya, Muraoka, Doi and Kawahito3 Another unique feature of A. urinae is its ability to produce biofilms by activating platelets on infected structures, which contributes to pathogenesis and results in suboptimal host defence. Reference Yaban, Kikhney and Musci5 Fluorescence in situ hybridisation, an emerging molecular biological method, can help identify pathogens that may have been missed in routine culture studies and help visualise the infection’s state of activity. In one study, two heart valve samples from two different patients with infective endocarditis were collected. Both were screened using the fluorescence in situ hybridisation technique, and the positive sections of tissue were sent for PCR amplification. This resulted in a 99.6% and 100% homology to A. urinae. From there, a fluorescently labelled probe AURI specific to A. urinae was designed. Reference Yaban, Kikhney and Musci5 This developing technique has the potential to significantly expedite the diagnosis of A. urinae infection.
Predisposing risk factors for A. urinae infective endocarditis include advanced age, male gender, urinary tract abnormalities, and cardiac abnormalities. Beyond advanced age, these risk factors warrant careful consideration even in the paediatric population. There are two other reported cases of A. urinae infective endocarditis in paediatrics aside from our case. One being an 11-year-old male with a history of unrepaired ventricular septal defect and imperforate anus, which is associated with an increased risk of urinary tract infections, largely due to recto urinary fistulas, coexisting urinary tract abnormalities, and potential bladder dysfunction. Reference Sous, Piwoz, Baer and Bhavsar7 The other reported paediatric case is a 17-year-old male with a native bicuspid aortic valve and an uncircumcised penis. Reference Qureshi and Patel8 Uncircumcised males have a 4–20 times higher risk of developing a urinary tract infection. Reference Morris and Wiswell9 This, combined with the presence of cardiac abnormalities, increases the patient’s susceptibility to A. urinae infective endocarditis. Our patient is a 15-year-old female with a history of atrioventricular septal defect and neurogenic bladder with vesicostomy. All three reported paediatric cases of A. urinae infective endocarditis occurred in patients with structural heart disease and additional risk factors for urinary tract infection.
A formal antibiotic treatment guideline for A. urinae infective endocarditis has not been established. Reference Sugaya, Muraoka, Doi and Kawahito3 Multiple regimens have reported efficacy. Penicillin is the first-line antibiotic reported in literature. Reference Meyer and Hug6 It is also reported that gentamicin has a synergistic effect in combination with penicillin and is distinctly beneficial if a biofilm has already formed. Reference Sugaya, Muraoka, Doi and Kawahito3,Reference Meyer and Hug6 Benzylpenicillin, ampicillin, meropenem, rifampicin, nitrofurantoin and vancomycin consist of the known susceptibility pattern of A. urinae. Reference Meyer and Hug6 Ciprofloxacin resistance has been reported. In addition to antibiotic therapy, surgical management was reported in 36.6% of all cases. Reference Meyer and Hug6
Our patient was initially treated with a 4-week ceftriaxone and metronidazole regimen, followed by mitral valve replacement operation, and a 6-week post-op gentamicin and penicillin treatment. In the reported case of the 11-year-old male with ventricular septal defect, the patient was initially treated with ceftriaxone and vancomycin after blood cultures grew gram-positive cocci in clusters for four consecutive days. Matrix-assisted laser desorption ionisation time-of-flight confirmed A. urinae as the causative pathogen. The antibiotic treatment then changed to penicillin G (MIC 0.047 mg/L). A notable complication in this patient’s course was the development of large mycotic pulmonary artery aneurysms secondary to septic emboli. This was repaired in surgery via right lower lobectomy and removal of the aneurysmal pulmonary artery segment that had perforated from the embolus. The patient received IV penicillin G for 6 weeks post operatively and had a successful recovery. Reference Sous, Piwoz, Baer and Bhavsar7 In the case of the 17-year-old male, the patient received a total of 6 weeks of penicillin and 3 weeks of gentamicin for synergy. The patient underwent an aortic valve replacement and a patch reconstruction of the noncoronary sinus and mitral valve anterior leaflet after resection of the mitral valve vegetation with no postoperative complications. A combination of penicillin and gentamicin therapy with surgical intervention resulted in successful clinical outcomes for the reported cases in the paediatric population.
Conclusion
Although A. urinae infective endocarditis is predominantly associated with advanced age, emerging evidence highlights a distinct vulnerability in paediatric patients with congenital heart defects and urinary tract abnormalities. Early recognition of these risk factors is critical for timely diagnosis and initiation of appropriate therapy. The limited but growing number of paediatric cases underscores the importance of clinical vigilance. Current reports support a management strategy combining penicillin and gentamicin, often supplemented by surgical intervention, which has demonstrated favourable outcomes. As diagnostic technologies advance and awareness increases, further research is essential to establish standardised treatment protocols and improve prognosis in this rare but potentially life-threatening condition.
Preoperative and postoperative echocardiogram. 10 (a) Preoperative image. (b) Postoperative image Ao: Aorta, LA: left atrium, LV: left ventricle, MV: mitral valve.

Figure 1 Long description
The preoperative echocardiogram image displays the left atrium, aorta, left ventricle, and mitral valve vegetation. The subaortic obstruction is clearly visible. The postoperative echocardiogram image shows the left ventricle, aorta, left atrium, and prosthetic mitral valve, with no subaortic obstruction present.
Financial support
None.
Competing interests
None.